Inhibitors of LAT1 transport activity, such as JPH203 and OKY-034, have been previously developed (53) and have undergone clinical trials in patients with pancreatic or biliary tract cancer (54). The gene discussed is SLC7A5; the disease is biliary tract neoplasm.